Becker’s Hospital Review highlights OHSU leadership news, including the appointments of Amy Shlossman as chief executive officer of OHSU Health system and executive vice president, and Maulin Patel, M.B.A., as chief financial officer and executive vice president.

The Oregonian reports on new requirements taking effect next year that potentially impact eligibility for Medicaid benefits. Daniel Nelson, M.D., says, “Medicaid’s structure is confusing even for people who are experts ... It becomes extraordinarily challenging for people to understand exactly what coverage they’ve got.”

OHSU researchers found that people with early-stage Huntington’s disease were able to safely follow a form of intermittent fasting, avoid unintended weight loss, and show improvements in measures of disease severity. Amie Hiller, M.D. says, “What was exciting about this study is that participants were able to maintain their weight while showing signs that the intervention may be positively affecting the disease itself."

PBS News Hour reports on mifepristone and how restricting access to the drug undermines its promise for treating conditions like uterine fibroids and endometriosis. Abby Liberty, M.D., says, “The United States will be left behind because of the red tape around these medicines and the way they have been politically framed … abortion stigma directly limits access to them and investment in them as a potential treatment option.”

Media report on Phil and Penny Knight’s $1.1 billion gift to Providence Health & Services, also mentioning the family’s $2 billion gift to OHSU’s Knight Cancer Institute.

News Medical covers a recent OHSU-led review that found emergency contraception containing mifepristone prevents more pregnancies with fewer side effects than some other common emergency contraceptive pills. Shaalini Ramanadhan, M.D., says, “Mifepristone in low-to-mid doses is a highly effective emergency contraceptive option that clinicians should know about.”

OHSU researchers found that people with early-stage Huntington’s disease were able to safely follow a form of intermittent fasting, avoid unintended weight loss, and show improvements in measures of disease severity. Amie Hiller, M.D. says, “What was exciting about this study is that participants were able to maintain their weight while showing signs that the intervention may be positively affecting the disease itself."

OHSU researchers found that people with early-stage Huntington’s disease were able to safely follow a form of intermittent fasting, avoid unintended weight loss, and show improvements in measures of disease severity. Amie Hiller, M.D. says, “What was exciting about this study is that participants were able to maintain their weight while showing signs that the intervention may be positively affecting the disease itself."

Becker’s Hospital Review highlights OHSU’s new AI-enabled outreach strategy that helps prepare patients for surgery without adding more staff. Kristen Lund, MN, RN, says, “The value of the agent is that it goes beyond just reading a script. Patients can ask for information to be clarified or repeated, request a call back at a specific time, and share concerns that require follow-up. When that happens, the scheduling team receives the information and can step in.”

OHSU researchers found that people with early-stage Huntington’s disease were able to safely follow a form of intermittent fasting, avoid unintended weight loss, and show improvements in measures of disease severity. Amie Hiller, M.D. says, “What was exciting about this study is that participants were able to maintain their weight while showing signs that the intervention may be positively affecting the disease itself."